VC  Shoreline Venture Management

     Office Locations:

275 Battery Street, 23rd Floor
San Francisco, CA 94111



  • Early
  • Seed



  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device



    Shoreline Venture Management, LLC is a venture capital firm established in 1998 to manage the Shoreline Venture Partners funds (SVP I and SVP II), as well as future investment funds. The firm's primary focus is on seed and early stage opportunities. Shoreline invests selectively in Healthcare Diagnostics, Healthcare IT, Novel Therapies and IT Infrastructure Software. The directors will consider opportunities in life sciences and the food, and food ingredient sectors. Shoreline's current commitments include food ingredients, soft drugs, commercial Internet privacy, supply chain logistics, digital asset identification and tracking, and networked data storage. The majority of the firm's portfolio companies are based in California and elsewhere in the United States. The Shoreline team has invested $80 million in 30 companies, a number of which have established leadership positions in their markets. Shoreline's initial investments are in seed and Series A rounds and range from $250,000 to $1 million and over the life of a portfolio company could total $8 million in multiple rounds.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Barry X. Lynn Venture Partner
    Bob Spears Managing Director
    Colin Harris Venture Partner
    Keith Corbin CFO
    Maria Pacella Managing Director


    Portfolio companies include:

        web link

      ARYx Therapeutics
        web link

      Attune Systems
        web link

        web link

      Boreal Genomics
        web link

      Build Direct
        web link

      CA API Management
        web link

        web link

      Copperleaf Technologies
        web link

      Health Hero
        web link


      Lifeline Technologies
        web link

      Patient Safe Solutions
        web link


        web link

        web link


        web link


    Recent News: